The antiarrhythmic drug quinidine has been shown to block several types of K' channel currents in cardiac preparations including the transient outward current ('to). To characterize the molecular mechanism of quinidine block, a cloned It.-type cardiac K' channel (RHK1) was expressed in Xenopus oocytes, and drug effects were examined on whole-cell and single-channel currents. Extracellular application of quinidine reduced whole-cell RHK1 current amplitude in a concentration-dependent manner. The block was voltage dependent, with an IC5s of 1.69 mM at 0 mV, and the value decreased to 875 ,uM at +60 mV. Quinidine significantly slowed the current inactivation time course during voltage-clamp pulses without changing the rate of activation or the steady-state inactivation. To test the channel-state dependence of quinidine block, the cells were "rested" in the presence of quinidine (500 ,uM) for 2 to 3 minutes before applying depolarizing pulses to +60 mV. During the first pulse, the current inactivation rate was slower than control, but the peak current was only reduced by less than 5%. Subsequent pulses reduced the peak current amplitude to 550%o of control. These results suggest that quinidine blocks the open channel and that the drug must first dissociate before the channel can close, thereby causing a crossover in current tracings. In measurements of single-channel current from cell-attached patches, open time was reduced by quinidine in a concentration-dependent manner. Single-channel current amplitude was not altered by quinidine. Application of quinidine to the intracellular side of inside-out patches had an effect similar to that obtained from cell-attached patches but at 10-fold lower concentrations. External quinidine may therefore have to pass into or through the cell membrane to reach its blocking site. (Circulation Research 1993;73:351-359 After injection, oocytes were kept in Barth's medium at 19°C. In some oocytes, incubation times longer than 3 days after injection produced a slowly inactivating K' current component in addition to the previously reported faster inactivating K' current. In this study,
Q uinidine is one of the most commonly used antiarrhythmic agents for various cardiac arrhythmias. The major effect of quinidine was thought to be a voltage-and frequency-dependent depression of Na+ channel current.1 However, quinidine generally prolongs the cardiac action potential duration in various cardiac preparations,2'3 an effect that cannot be explained solely by Na+ channel blockade. Multiple voltage-dependent K' channels contribute to the repolarization phase of the cardiac action potential, and the quinidine-induced prolongation of the action potential has, more recently, been attributed to suppression of the delayed rectifier K' channel current (IK)2'4'5 and the inward rectifier K' channel current (IK,).6
In ventricular cells, quinidine produces a delay in the activation time of IK without a significant change in the deactivation time.57 In contrast, in sinoatrial and atrioventricular cell aggregates, quinidine significantly slows deactivation time of IK without changing the activation time course.4 These results are probably due to the differences in the channel gating kinetics and drug-channel interactions among various tissues. However, quinidine also blocks other time-dependent outward K' channel currents, such as the transient outward current (Ito). [8] [9] [10] [11] There is a species-dependent variability of Io,12-15 and it is likely that quinidine interacts with multiple components of K' channel current to produce different actions in different tissues. Studies of the action of quinidine on each component of the K' channel current are required to characterize its pharmacological profile.
Recent advances in the combined techniques of molecular biology and electrophysiology have made it possible to test the effects of pharmacological agents on specific ion channel currents. A transient outward-type K' channel (RHK1) cloned from rat heart is approximately 98% identical to a cloned human K' channel (HK1) and also shows very similar channel properties to HK1. ,to influences both the duration and the amplitude of the cardiac action potential plateau,12 we examined the effects of quinidine on whole-cell and single-channel currents expressed in Xenopus oocytes after injection of RHK1 cRNA.
Materials and Methods
A cDNA encoding RHK1 was previously isolated from a rat heart cDNA library. 16 Membrane Potential (mV) current was monitored by applying depolarizing pulses. Steady-state conditions were reached 2 to 3 minutes after drug application, and the effects were reversible upon washout of the drug. The current typically recovered to within 80% to 90% of control values. In addition to decreasing peak current amplitude, quinidine slowed the rate of current decay (Fig 2) . The falling phase of current, in the absence or presence of the drug, was well fitted to a single exponential. In the presence of quinidine (500 1tM), the inactivation time constant was increased from 46.8 to 118 milliseconds (Fig 2, A) . The rate of inactivation at various test potentials is plotted in Fig 2, B . Under control conditions, inactivation rates were slightly voltage dependent; the rate was slightly faster at positive potentials, and quinidine decreased the rate of inactivation at all potentials. Although current activation was well fitted by a sigmoidal function after the capacitative current transient, capacitative current compensation was not always complete. Therefore, half activation time (T1/2) was measured in place of the activation time constant. In the absence of drug, T1/2 at +60 mV was 3.8±0.12 milliseconds (n=8) and was not significantly affected by quinidine (500 ,/M, 3.7+0.1 milliseconds, n=6). The effect on the inactivation rate was concentration dependent, and an increase in the inactivation time constant was apparent at 100 ,uM quinidine. The relative increase at a concentration of 100 4ttM quinidine as compared with control, at a potential of + 60 mV, was a factor of 1.2±0.3 (n=4).
To assess the voltage dependence of quinidine block, the half-inhibiting concentration, IC50, was measured at different voltages (Fig 3) . and plotted in Fig 3, B , as log IC50 versus membrane potential. Experimental points were fitted to a theoretical one-to-one drug binding to RHK1 in Fig 3, A. The IC50 was reduced at more positive potentials. IC50s for 0 and +60 mV were 1686 and 875 ,uM, respectively. Assuming that the blocking agent acts by moving to its site of action and that the site at which quinidine binds is within the membrane electrical field, we calculated the location of the quinidine binding site according to the Woodhull model23 used to describe the proton block of Na+ current in frog node:
(1) Kd=Kd(O)exp(-z8VF/RT) where Kd(O) is the dissociation constant at zero membrane potential, z is the blocking ion valence of + 1, 8 is a value between 0 and 1 and is the electrical distance from the outside, V is membrane potential, and F, R, and T are their usual thermodynamic characteristics. IC50 was substituted for Kd. For the cell shown in Fig 3, B (inset), IC50 decreased e-fold for a 76-mV change in potential. From Equation 1, the straight line in Fig 3, 
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To further elucidate the effects of quinidine, the voltage dependence of inactivation of RHK1 was measured using a double-pulse procedure (Fig 4) . Quinidine at a concentration of 500 ttM produced no detectable shift in the inactivation-potential relation. The midpoint voltage for a Boltzmann distribution and slope factor k were indistinguishable in the absence or presence of quinidine and were -62±0.8 and 4.5+0.2 mV (n=8), respectively.
The slowing of RHK1 current inactivation by quinidine was reminiscent of the block of sodium conductance by the quaternary drug strychnine in squid axons. 24 Therefore, we tested the possibility that quinidine may act as an open-channel blocker of RHK1. In Fig 5 we tested the possible use-dependent effects of quinidine on RHK1. Under control conditions, the current recovery from inactivation required more than 10 seconds; therefore, care was taken to rest the cell for 15 seconds before each test depolarization. The cell was superfused with quinidine (500 ,uM) for 2 minutes before successive depolarizing pulses were applied. The peak current elicited by the first pulse was only marginally reduced, but the current decayed more slowly ( Fig  5, A, tracing 1) . Successive depolarizations further reduced the amplitude of the current and the rate of current decay (Fig 5, B) . A steady-state level of block was reached after about 10 pulses. After removal of the drug, the current elicited by the first voltage step recovered to approximately 80% of the control value (Fig 5, C, tracing W) . The entire time course of quinidine block in this experiment is shown in Fig 5, D. Longer periods of rest were required during the recovery phase to achieve a complete relief of the block. Similar results were obtained in six additional experiments. The data suggest that quinidine block required the channel to be open and that quinidine must first unbind from the channel before it can close, thereby slowing the rate of current decay. The recovery from block occurred slowly during the rest period.
Quinidine Blockade of Single-Channel Currents
To further examine the mechanism of quinidine blockade of RHK1, we carried out single-channel recordings. Fig 6, A, shows typical single-channel currents recorded in the cell-attached configuration. Singlechannel currents were elicited by depolarizing clamp pulses to +60 mV from a holding potential of -80 mV every 5 seconds with 5.4 mM K' on the extracellular side.
Under control conditions, channel openings occurred immediately after the voltage jump during each pulse. The averaged current displayed a fast activation, which peaked at =20 milliseconds, followed by a slower inactivation. The decay phase of the current was fitted by a single exponential (lowest tracing in Fig 3, A) . Examples of channel activity from the same patch before and after perfusion of 200 ,uM quinidine are shown in Fig 6. In the presence of quinidine, the pattern of channel activity was altered. In addition to the opening at the beginning of each pulse, openings occurred in brief bursts throughout the pulse. If The lack of a detectable effect of quinidine at lower concentrations suggested that the highly lipophilic intracellular environment (yolk) of the oocyte might interfere with the ability of quinidine to reach its binding site at the membrane by acting as a sink and sequestering the drug. To examine this possibility, we measured (Fig 8, A) . To compare the channel activity before and after application of quinidine, single-channel currents during each tracing were integrated and plotted cumulatively against the tracing number in Fig 8, In the present study, we found that quinidine produces slower current inactivation, causing crossover between control current and those recorded in the presence of quinidine.
The drug concentrations needed to produce inhibition of RHK1 currents were about 50 times higher than those required to produce an equivalent block in cardiac myocytes. The reason for this is unclear. It is possible that some cofactor that modulates drug-channel interactions may be missing in the homotetrameric channels expressed from the single type of cRNA. Another possibility is that the expressed channels are not posttranslationally processed properly by the Xenopus oocyte. Similar differences in recovery from inactivation kinetics have been noted previously between native I. and expressed Ito-type currents.16'7 Conversely, the expressed channel structure and function may be equivalent to the native state, but the altered drug response may reflect an alteration in the ability of the drug to reach its site of action. Closed Time (ms) Our data suggest that quinidine most likely acts within the membrane field. The higher concentrations of quinidine needed to produce detectable effects in whole-cell and cell-attached experiments might be explained by the presence of a highly lipophilic compartment within the oocyte, the yolk, which may behave as an intracellular sink for the drug, thereby lowering the effective concentration at its site of action at the cellular membrane. This suggestion is consistent with our observation that the channels are more sensitive to quinidine when the drug is applied to the intracellular face of inside-out patches. In this regard, the pharmacokinetic problem of getting quinidine to its site of action may limit the interpretation of results, particularly when comparing drug concentrations between oocytes and cardiac myocytes. Potential differences in effective drug concentration at the cytoplasmic surface of the ion channel may lead to differences in apparent drug affinity and rate constants. However, this does not limit the usefulness of the oocyte preparation in the elucidation of the molecular mechanisms of quinidine action on RHK1. Expression of RHK1 in other systems such as mammalian cells should help to provide a more quantitative analysis of the effects of quinidine.
Although no single-channel data on the properties of RHK1 are available, the conductance of the channel (10 picosiemens) we observed in this study is similar to the value of 9.9 picosiemens for I, in guinea pig ventricular myocytes.5 Quinidine-induced changes in the time course of inactivation of whole-cell RHK1 currents suggest that the drug acts as an open-channel blocker. Single-channel measurements show that the mean open time became shorter as the drug concentration increased. The time between the beginning of the pulse and the first channel opening was not altered by exposure to quinidine. The persistence of channel reopening throughout the depolarizing pulses suggests that the drug does not increase the rate of transition to the inactivated state. These features of quinidine block of single RHK1 channel currents support the idea that quinidine molecules bind to and block the open channel. The blocked channel must unblock before closing; therefore, inactivation of RHK1 currents was slowed in the presence of quinidine. A similar mechanism of open K' channel block by 4-aminopyridine has been demonstrated in B lymphocytes. 25 In the present study, quinidine block was weakly voltage dependent; the effects were potentiated by depolarization, indicating that quinidine might act by moving to its site of action within the membrane electric field. The voltage-dependent block of K' channels by various ions and drugs has been modeled with a twobarrier one-site model. 23 The fact that quinidine block increased as the probability of RHK1 channel opening increased also supports 
